Brief: Biosynex Launches Capital Increase Of Minimum EUR 8 Mln
Jan 28 (Reuters) - BIOSYNEX SA ALBIO.PA :
* LAUNCH OF CAPITAL INCREASE OF MINIMUM EUR 8 MILLION
* SETTLEMENT AND DELIVERY OF NEW SHARES AND THEIR ADMISSION
TO
TRADING ON EURONEXT GROWTH PARIS MARKET SCHEDULED FOR FEB 2,
2021
Source text for Eikon: urn:newsml:reuters.com:*:nNDL41c62V
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals